IRYCIS Outstanding publication

• Tuesday, 3 November 2026

  De La Torre Tarazona E, Moraga E, Vaquer R, Sánchez S, de Lazzari E, Luna L, Vicens S, García LJ, Peraire J, Garcia M, Balsalobre L, Guillén S, López LF, Jarrín I, Serrano S, Alcamí J, Moreno S, CoRIS C. Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size

  Sci Rep. 2025

  10.1038/s41598-025-09474-1

• Tuesday, 27 October 2026

  Garcia C, Quiñones J, Brox N, Martinez A, Ruz I, Arias HP, Manso SA, Garcia AM, Rosillo M, Luengo P, Guerrero BP, García Gómez Muriel MI, Casado CF, Pamplona MJ, Lázaro VA, Paja M, Guijarro de Armas MG, Bolaños PI, Valderrabano P. Outcomes of patients with low-risk differentiated thyroid cancer with an excellent response to initial therapy

  Eur Thyroid J. 2026

  10.1530/ETJ-26-0223

• Tuesday, 20 October 2026

  Navarro-Soler R, Muriel A, Fanciulli C, Bernardino JI, Sáez C, Zamora J, Fernández-Félix BM, García-Ruíz de Morales AG, Poveda E, Mena de Cea Á, Martínez-Sanz J, Moreno S, Serrano-Villar S, CoRIS Cohort. Towards tuberculosis elimination in people with HIV on antiretroviral therapy: evidence from a two-decade nationwide cohort in Spain

  Infect Dis Poverty. 2026

  10.1186/s40249-026-01426-9

• Wednesday, 14 October 2026

  Veiga JL, Monreal E, Espiño M, Chico JL, Fernández JI, Rodríguez F, Villarrubia N, Rodero A, Sainz de la Maza S, Masjuan J, Costa L, Villar LM. Kappa index: real-world study for assessing cut-off values that provide the best accuracy for multiple sclerosis diagnosis in patients with CIS

  Front Immunol. 2026

  10.3389/fimmu.2026.1771566